Kirjojen hintavertailu – 12 859 829 kirjaa ja 27 kauppaa

Kirjailija

Andrew W. Mulcahy

Kirjat ja teokset yhdessä paikassa: 3 kirjaa, julkaisuja vuosilta 2014–2016, suosituimpiin kuuluu Toward a Sustainable Blood Supply in the United States. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

3 kirjaa

Kirjojen julkaisuvuodet: 2014–2016.

Toward a Sustainable Blood Supply in the United States

Toward a Sustainable Blood Supply in the United States

Andrew W. Mulcahy; Kandice A. Kapinos; Brian Briscombe; Lori Uscher-Pines; Ritika Chaturvedi; Spencer R. Case; Jakub Hlavka; Benjamin M. Miller

RAND
2016
pokkari
This report describes the status quo in the U. S. blood system, explores a set of six specific research questions related to the sustainability of this system through analysis and discussion, and presents policy alternatives and recommendations that aim to improve blood system is sustainability. We employed a mixed-methods approach, blending insight from analyses of available data and from interviews and other interactions with stakeholders.
Health Sector Reform in the Kurdistan Regioniraq

Health Sector Reform in the Kurdistan Regioniraq

C. Ross Anthony; Melinda Moore; Lee H. Hilborne; Andrew W. Mulcahy

RAND
2014
pokkari
This report summarizes analysis of three distinct but intertwined health policy issue areas for the Kurdistan Regional Government: health financing, primary care, and quality and patient safety. The researchers assessed policy options, developed plans to overcome barriers and achieve policy objectives, and developed and helped implement a new management information system.
Redirecting Innovation in U.S. Health Care

Redirecting Innovation in U.S. Health Care

Steven Garber; Susan M. Gates; Emmett B. Keeler; Mary E. Vaiana; Andrew W. Mulcahy; Christopher Lau; Arthur L. Kellermann

RAND
2014
pokkari
New medical technologies are a leading driver of U. S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases.